Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 10, 2004

Primary Completion Date

October 24, 2005

Study Completion Date

October 24, 2005

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

DRUG

insulin glargine

DRUG

metformin

Trial Locations (1)

Novo Nordisk Investigational Site, Istanbul